Hanhong Technology is a biomedicine firm that was founded in 2003. The company is dedicated to advancing drug research, pioneering synthetic biology, and creating pharmaceutical intermediates. With a focus on Biopharma, Manufacturing, and Pharmaceutical industries, Hanhong Technology recently received a CNY100.00M Series A investment on 11 December 2023. This investment was led by WisdoMont Asset Management and Jinshuihu Fund. Hanhong Technology's commitment to innovative biomedicine solutions places it at the forefront of the industry's evolution.
No recent news or press coverage available for Hanhong Technology.